BioData secure follow-on funding after exceptional year

We’re delighted to announce follow-on funding for our portfolio company BioData, producers of the lab research management software Labguru. 

The company has had a tremendous year to date, launching a free iPad app designed to play off the strengths of their flagship web app, as well as securing Technion’s Rappaport Institute as a customer and integrating some of the best peer-reviewed protocols into their system. 

From their press release, issued today:

“BioData and Digital Science exist at a time when scientists are changing long-established habits and increasingly adopting digital productivity tools out of necessity to remain competitive. This is an exciting time for all of the BioData team. We enjoy support from Digital Science along with an ongoing dialog with top researchers worldwide – ensuring we develop the lab management tools a research group needs in order to do great science,” said Jonathan Gross, Founder and Co-CEO of BioData. “We have invested a lot this year in rebranding and revamping the product, building a winning team, and developing tools to better serve our growing user base.”

The news from BioData follows a similar announcement from another one of our portfolio companies 1DegreeBio, a testament to the work being done by both of these startups and our belief in the promise of their products. 

“BioData has had a tremendous year. Labguru is proving to be a powerful and distinctive product, and customer feedback has been excellent. It really is changing the way that researchers work,” said Timo Hannay, Managing Director, Digital Science. “We are delighted to have BioData as part of our portfolio, and look forward to even greater success in the year to come.”

Congratulations again to our colleagues at BioData. Stay tuned for more in the coming months.